Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $435K | ﹤0.01% |
+9,000
| New | +$435K |
|
3027
Invesco Financial Preferred ETF
PGF
$672M
| $433K | ﹤0.01% |
30,100
+12,302
| +69% | +$182K |
|
|
EDN
3028
Edenor
EDN
$1.09B
| $432K | ﹤0.01% |
+54,072
| New | +$381K |
|
3029
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
| $432K | ﹤0.01% |
5,100
+200
| +4% | +$17.1K |
|
3030
HNI Corp
HNI
$3.53B
| $432K | ﹤0.01% |
15,200
+2,600
| +21% | +$73.9K |
|
3031
Oppenheimer Holdings
OPY
$1.22B
| $432K | ﹤0.01% |
10,200
-26,700
| -72% | -$983K |
|
|
HLTH
3032
DELISTED
Cue Health Inc. Common Stock
HLTH
| $431K | ﹤0.01% |
208,100
+7,500
| +4% | +$23.7K |
|
|
DOMA
3033
DELISTED
Doma Holdings, Inc.
DOMA
| $431K | ﹤0.01% |
38,024
+276
| +0.7% | +$3.12K |
|
3034
Verrica Pharmaceuticals
VRCA
$92.1M
| $430K | ﹤0.01% |
15,637
-7,393
| -32% | -$197K |
|
3035
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $428K | ﹤0.01% |
4,600
+2,100
| +84% | +$194K |
|
3036
Optical Cable Corp
OCC
$138M
| $427K | ﹤0.01% |
96,503
-8,600
| -8% | -$31.9K |
|
3037
Gold Royalty Corp
GROY
$662M
| $426K | ﹤0.01% |
182,920
+48,084
| +36% | +$120K |
|
|
OPTN
3038
DELISTED
OptiNose
OPTN
| $422K | ﹤0.01% |
15,220
-2,707
| -15% | -$103K |
|
3039
Vanguard S&P 500 ETF
VOO
$1.01T
| $422K | ﹤0.01% |
+1,200
| New | +$424K |
|
|
AEVA
3040
Aeva Technologies
AEVA
$1.73B
| $420K | ﹤0.01% |
61,800
+12,591
| +26% | +$110K |
|
3041
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$8.71B
| $420K | ﹤0.01% |
10,600
-55,700
| -84% | -$2.18M |
|
3042
Tenaya Therapeutics
TNYA
$157M
| $420K | ﹤0.01% |
209,079
+42,879
| +26% | +$105K |
|
3043
Q32 Bio
QTTB
$482M
| $420K | ﹤0.01% |
18,509
-2,552
| -12% | -$67.7K |
|
3044
Dimensional US Small Cap ETF
DFAS
$15.6B
| $419K | ﹤0.01% |
+8,200
| New | +$422K |
|
3045
Highway Holdings
HIHO
$4.72M
| $419K | ﹤0.01% |
199,315
-9,800
| -5% | -$21.3K |
|
3046
Addus HomeCare
ADUS
$2.22B
| $418K | ﹤0.01% |
+4,200
| New | +$439K |
|
3047
ClearPoint Neuro
CLPT
$408M
| $418K | ﹤0.01% |
+49,337
| New | +$468K |
|
3048
Emerson Radio
MSN
$7.71M
| $418K | ﹤0.01% |
788,288
-19,900
| -2% | -$11.2K |
|
3049
RAVE Restaurant Group
RAVE
$44.5M
| $418K | ﹤0.01% |
264,864
+21,064
| +9% | +$33.6K |
|
3050
Smith Micro Software
SMSI
$15.7M
| $418K | ﹤0.01% |
4,975
-1,735
| -26% | -$151K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.